Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00234156 · ClinicalTrials.gov registry record · NA
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
A NA study, sponsored by Rockefeller University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00234156: Completed NA study, sponsored by Rockefeller University.
NCT00234156 is a NA study that has completed, run by Rockefeller University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00234156, a NA study, has completed, sponsored by Rockefeller University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will evaluate how a common dietary sugar (fructose) raises blood fats (triglycerides). We will determine whether the production of fat from fructose is higher in dialysis patients compared to healthy volunteers. Dialysis patients have high levels of hormone-like substances called cytokines that may increase blood fats. The results will help set better guidelines for diets for the general population and patients with kidney disease who are at high risk for heart attack and stroke. There will be one or two outpatient screening visit(s) and a one-week (6 nights) stay at the Rockefeller University Hospital.
Interventions
- PROCEDURE oral fructose and high fat diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-09 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00234156 record still lists
NCT00234156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which oral fructose and high fat diet is the first listed.
NCT00234156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00234156 about?
NCT00234156 is a clinical study titled "The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers". This study will evaluate how a common dietary sugar (fructose) raises blood fats (triglycerides). We will determine whether the production of fat from fructose is higher in dialysis patients compared to healthy volunteers. Dialysis patients have high levels of hormone-like substances called cytokine...
What is the current status of trial NCT00234156?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2004-09. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00234156?
The interventions under investigation include: oral fructose and high fat diet (PROCEDURE).
Who is sponsoring clinical trial NCT00234156?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00234156's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia